4 DMT Climbs as Gene Therapy Patients Keep Jettisoning Jabs Climb
02 Aug 2025 //
FIERCE BIOTECH
Sanofi pens $395M China pact for Arrowhead Metabolic med
02 Aug 2025 //
PRESS RELEASE
Spine Bio Pharma Misses Primary Endpoint in Back Pain Phase 3
02 Aug 2025 //
FIERCE BIOTECH
Allogene Reports Patient Death, Discontinues CAR-T Pivotal Trial
02 Aug 2025 //
FIERCE BIOTECH
FDA Declines to Approve Regeneron`s Blood Cancer Drug
02 Aug 2025 //
REUTERS
Frazier Life Sciences raises $1.3B for early-stage biotech fund
01 Aug 2025 //
FIERCE BIOTECH
Altascience, VoxCell Collaborate for Preclinical Drug Development
31 Jul 2025 //
BUSINESSWIRE
Twist Bioscience Launches Humanized Transgenic Mouse Model
31 Jul 2025 //
BUSINESSWIRE
Nosis Nominates Development Candidate for Lead Fibrosis Program
31 Jul 2025 //
BUSINESSWIRE
Vir Biotech Launches 2nd Global Trial for Chronic Hepatitis Delta
31 Jul 2025 //
BUSINESSWIRE
FDA Approves SetPoint Medical`s Therapy for Rheumatoid Arthritis
31 Jul 2025 //
BUSINESSWIRE
Lantern Finishes Enrollment for LP-300 Lung Cancer Trial in Japan
31 Jul 2025 //
BUSINESSWIRE
FDA Confirms Meeting on Corticorelin Phase 3 Study
31 Jul 2025 //
PHARMAWEB
Biogen Boosts Sales Forecast as `New Biogen` Emerges
31 Jul 2025 //
FIERCE PHARMA
Nuvectis Halts Ovarian Cancer Program Following Phase 1b Data
31 Jul 2025 //
FIERCE BIOTECH
AbbVie Halts IL-1 Asset Development for Ulcerative Colitis
31 Jul 2025 //
FIERCE BIOTECH
Instil`s PD-L1xVEGF Bispecific Shows Promise in China
31 Jul 2025 //
FIERCE BIOTECH
Biogen’s Leqembi Advances as CEO Eyes Pipeline Rebuild
31 Jul 2025 //
BIOSPACE
BMS` Cobenfy Future Uncertain After Phase III Failure
31 Jul 2025 //
BIOSPACE
Immunocore`s Q2 2025 Financial Results and Call on August 7, 2025
31 Jul 2025 //
GLOBENEWSWIRE
ImmuneOnco Shares Early IMM2510 NSCLC Trial Data in China
31 Jul 2025 //
GLOBENEWSWIRE
Pasithea Completes Dosing for PAS-004 Ph1 NF1 Trial in Adults
31 Jul 2025 //
GLOBENEWSWIRE
BriaCell Includes UCLA Health in Phase 3 Breast Cancer Study
31 Jul 2025 //
GLOBENEWSWIRE
Crescent Bio`s Q2 2025 Financial Results & Business Highlights
31 Jul 2025 //
GLOBENEWSWIRE
CytomX Therapeutics Set to Report Q2 2025 Financial Results
31 Jul 2025 //
GLOBENEWSWIRE
Avadel Pharmaceuticals` Q2 2025 Financial Results on Aug 7
31 Jul 2025 //
GLOBENEWSWIRE
Nautilus Biotech`s Q2 2025 Financial Results Released
31 Jul 2025 //
GLOBENEWSWIRE
VedTechBio Launches Drug Discovery AI, Partners with AlphaMeld
31 Jul 2025 //
GLOBENEWSWIRE
MaxCyte, Anocca AB Partner for Advancement of TCR-T Cell Therapy
31 Jul 2025 //
GLOBENEWSWIRE
Myriad Genetics Secures New $200M Credit Facility
31 Jul 2025 //
GLOBENEWSWIRE
Oragenics Picks Southern Star for ONP-002 Ph IIa Trial Research
31 Jul 2025 //
GLOBENEWSWIRE
Palisade Gets Patent Approval for PALI-2108 Composition in China
31 Jul 2025 //
GLOBENEWSWIRE
Dyadic International Prices Public Offering of 6,052,000 Shares
31 Jul 2025 //
GLOBENEWSWIRE
GRI Bio Reveals 6-Week Biomarker Data in Phase 2a IPF Study
31 Jul 2025 //
GLOBENEWSWIRE
GRI Bio CEO, Marc Hertz, Joins Virtual Investor Segment
31 Jul 2025 //
GLOBENEWSWIRE
PolTREG, Immuthera Get Positive FDA Nod for Pre T1D Trial
31 Jul 2025 //
GLOBENEWSWIRE
Ligand, Medtronic Invest $70M in Orchestra BioMed
31 Jul 2025 //
GLOBENEWSWIRE
Elutia`s Q2 2025 Financial Results to be Reported on August 14
31 Jul 2025 //
GLOBENEWSWIRE
Bionano`s Q2 2025 Financial Result & Conference Call on August 14
31 Jul 2025 //
GLOBENEWSWIRE
Larimar Therapeutics Closes Public Offering & Option Exercise
31 Jul 2025 //
GLOBENEWSWIRE
FibroBiologics Announces Q2 2025 Financial Results and Update
31 Jul 2025 //
GLOBENEWSWIRE
Silexion Therapeutics Raises $1.8M Through Warrant Exercise
31 Jul 2025 //
GLOBENEWSWIRE
Meitheal Pharmaceuticals Boosts Medical Affairs with 2 New Hires
31 Jul 2025 //
CONTRACTPHARMA
China’s Obesity Market Driven By Local Drugs, Pipeline
31 Jul 2025 //
EXPRESSPHARMA
Symbiosis Achieves 1,000th Injectable Drug Batch Milestone
31 Jul 2025 //
EXPRESSPHARMA
Imfinzi Gets Priority Review, Breakthrough Therapy Status in US
31 Jul 2025 //
INDPHARMAPOST
ScaleReady Grants G-Rex® Awards To Minnesota Researchers
31 Jul 2025 //
PR NEWSWIRE
Azenta with Frenova & Nephronomics for Nephrology Research
31 Jul 2025 //
PR NEWSWIRE
Chipscreen`s Brain-Penetrant Aurora B Inhibitor Gets IND Approval
31 Jul 2025 //
PR NEWSWIRE
Leqembi® Q2 2025 Sales Reach 23.1 Billion Yen
31 Jul 2025 //
PR NEWSWIRE
Marengo Therapeutics Appoints Dr. Dolsten to Board, Dr. Tabernero
31 Jul 2025 //
PR NEWSWIRE
Mezzion Pharma Hits Enrollment Milestone in Largest Fontan Trial
31 Jul 2025 //
PR NEWSWIRE
Actinium Reveals ATNM-400`s Superior Efficacy in Prostate Cancer
31 Jul 2025 //
PR NEWSWIRE
Immunophotonics Ends Injectabl-1 Trial For Advanced Solid Tumors
31 Jul 2025 //
PR NEWSWIRE
Madrigal Makes Potential $2B+ Bet for CSPC`s GLP-1 Pill
31 Jul 2025 //
BIOSPACE
Biogen, Eisai’s Leqembi Slows Alzheimer’s Over 4-Year Treatment
31 Jul 2025 //
BIOSPACE
GSK anti-TIM-3 antibody flunks ph. 3, as TIGIT fail costs $629M
31 Jul 2025 //
FIERCE BIOTECH
Vyne`s BET Inhibitor Fails Phase 2 Vitiligo Trial, Sinking Stock
31 Jul 2025 //
FIERCE BIOTECH
Evotec, Sandoz Expand Deal, May Sell Toulouse Biologics Site
31 Jul 2025 //
ACCESSWIRE
Actio Biosciences Gets FDA Clearance and Fast Track for ABS-1230
30 Jul 2025 //
BUSINESSWIRE